Metastases-directed therapy in addition to standard systemic therapy in oligometastatic castration resistant prostate cancer: A randomized phase II trial (GROUQ-PCS 9).

Authors: Tamim Niazi, Fred Saad, Rashmi Koul, Isabelle Thibault, Peter W. M. Chung, George Wakil, Michael Lock, Guila Delouya, Boris Bahoric, Andrew Feifer, Venkata Ramana Agnihotram, Theodoros Tsakiridis, Fabio L. Cury, Rafika Dahmane, Steven Tisseverasinghe, Nikhilesh Gajanan Patil, Scott Tyldesley

Published: 2025-02-18

DOI: 10.1200/jco.2025.43.5_suppl.22

Source: Full article

Metastases-directed therapy in addition to standard systemic therapy in oligometastatic castration resistant prostate cancer: A randomized phase II trial (GROUQ-PCS 9).

Abstract